Discussion of Issues concerning Orphan Drugs – Video

In the United States, the median price for an orphan drug is about $100,000 per year, twenty times the price of the median non-orphan drug. Given the staggering cost, you’d think we’d have a solid handle on whether that money is well-spent. But the truth is that we don’t. Nick Bagley, a professor of law at the University of Michigan discusses this topic in the first of a four-part series.